These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 29314171)

  • 21. Fundus autofluorescence as a marker of disease severity in Vogt-Koyanagi-Harada disease.
    Morita C; Sakata VM; Rodriguez EE; Abdallah SF; Lavezzo MM; da Silva FT; Machado CG; Oyamada MK; Hirata CE; Yamamoto JH
    Acta Ophthalmol; 2016 Dec; 94(8):e820-e821. PubMed ID: 27368955
    [No Abstract]   [Full Text] [Related]  

  • 22. Vogt-Koyanagi-Harada-like syndrome induced by immune checkpoint inhibitors in a patient with melanoma.
    Yoshida S; Shiraishi K; Mito T; Sayama K
    Clin Exp Dermatol; 2020 Oct; 45(7):908-911. PubMed ID: 32394515
    [No Abstract]   [Full Text] [Related]  

  • 23. A Rare Cause of Uveitis: Vemurafenib.
    Sızmaz S; Görkemli N; Esen E; Demircan N
    Turk J Ophthalmol; 2018 Dec; 48(6):323-325. PubMed ID: 30605942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bilateral Nivolumab-associated Vogt-Koyanagi-Harada-like Uveitis in a Patient with Metastatic Renal Cell Carcinoma].
    Czichos C; Wawrzynów B; Chamalis C; von Jagow B
    Klin Monbl Augenheilkd; 2021 Jun; 238(6):711-714. PubMed ID: 33395707
    [No Abstract]   [Full Text] [Related]  

  • 25. Intraocular Inflammation Associated with New Therapies for Cutaneous Melanoma - Case Series and Review.
    Fierz FC; Meier F; Chaloupka K; Böni C
    Klin Monbl Augenheilkd; 2016 Apr; 233(4):540-4. PubMed ID: 27116532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect on choroidal changes of the route of systemic corticosteroids in acute Vogt-Koyanagi-Harada disease.
    Park UC; Cho IH; Lee EK; Yu HG
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1203-1211. PubMed ID: 28382438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vogt-Koyanagi-Harada disease.
    O'Keefe GA; Rao NA
    Surv Ophthalmol; 2017; 62(1):1-25. PubMed ID: 27241814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Vogt-Koyanagi-Harada syndrome (clinical cases)].
    Sorokin EL; Voronina NV; Avramenko SY; Pomytkina NV
    Vestn Oftalmol; 2015; 131(3):90-98. PubMed ID: 26310014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Choroidal thickness in eyes with posterior recurrence of Vogt-Koyanagi-Harada disease after high-dose steroid therapy.
    Hashizume K; Imamura Y; Fujiwara T; Machida S; Ishida M; Kurosaka D
    Acta Ophthalmol; 2014 Sep; 92(6):e490-1. PubMed ID: 24588838
    [No Abstract]   [Full Text] [Related]  

  • 30. ACUTE EXUDATIVE PARANEOPLASTIC POLYMORPHOUS VITELLIFORM MACULOPATHY DURING VEMURAFENIB AND PEMBROLIZUMAB TREATMENT FOR METASTATIC MELANOMA.
    Sandhu HS; Kolomeyer AM; Lau MK; Shields CL; Schuchter LM; Nichols CW; Aleman TS
    Retin Cases Brief Rep; 2019 Spring; 13(2):103-107. PubMed ID: 28614138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incomplete Vogt-Koyanagi-Harada disease following treatment with encorafenib and binimetinib for metastatic melanoma.
    Diamantopoulos PT; Stoungioti S; Anastasopoulou A; Papaxoinis G; Gogas H
    Melanoma Res; 2018 Dec; 28(6):648-651. PubMed ID: 30169430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vogt-Koyanagi-Harada Syndrome following influenza vaccination.
    Kim M
    Indian J Ophthalmol; 2016 Jan; 64(1):98. PubMed ID: 26953036
    [No Abstract]   [Full Text] [Related]  

  • 33. Vogt-Koyanagi-Harada disease after stapedotomy.
    Accorinti M; Gilardi M; Nardella C; Amorelli GM; Pesci FR
    Eur J Ophthalmol; 2015 Oct; 25(6):e127-30. PubMed ID: 25982211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vogt-Koyanagi-Harada-like Syndrome Complicating Pembrolizumab Treatment for Metastatic Melanoma.
    Bricout M; Petre A; Amini-Adle M; Bezza W; Seve P; Kodjikian L; Dalle S; Thomas L
    J Immunother; 2017; 40(2):77-82. PubMed ID: 28166182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vogt-Koyanagi-Harada disease: diagnosis and treatments update.
    Bordaberry MF
    Curr Opin Ophthalmol; 2010 Nov; 21(6):430-5. PubMed ID: 20829689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Late posterior segment relapses in a series of Vogt-Koyanagi-Harada disease.
    Errera MH; Levinson RD; Fardeau C; Thomas D; Cohen D; Navarro A; Héron E; Paques M; Pavesio C; Sahel JA; Westcott MC; Gaudric A; LeHoang P; Bodaghi B
    Acta Ophthalmol; 2015 Sep; 93(6):e509-10. PubMed ID: 25604241
    [No Abstract]   [Full Text] [Related]  

  • 37. Vogt-Koyanagi-Harada disease in 3-year-old boy.
    Takada S; Tanaka R; Kurita N; Ishii K; Kaburaki T
    Clin Exp Ophthalmol; 2015 Aug; 43(6):593-4. PubMed ID: 25711345
    [No Abstract]   [Full Text] [Related]  

  • 38. Case of severe acneiform eruptions associated with the BRAF inhibitor vemurafenib.
    Ansai O; Fujikawa H; Shimomura Y; Abe R
    J Dermatol; 2017 Mar; 44(3):e15-e16. PubMed ID: 27511106
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of Vogt-Koyanagi-Harada syndrome in pregnancy.
    Tien MC; Teoh SC
    Can J Ophthalmol; 2009 Apr; 44(2):211-2. PubMed ID: 19491962
    [No Abstract]   [Full Text] [Related]  

  • 40. Severe pan-uveitis in a patient treated with vemurafenib for metastatic melanoma.
    Wolf SE; Meenken C; Moll AC; Haanen JB; van der Heijden MS
    BMC Cancer; 2013 Dec; 13():561. PubMed ID: 24289205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.